Evidence map›Paper›PMID 39334021›Full record

ArticleBMC cancer2024

Understanding m6A changes in chromophobe renal cell carcinoma and predicting patient outcomes survival.

Zhigang Chen, Junbo Yang, Wei Zhang, Yang Qian, Nan Zhang, Zixin Chen, Min Lu, Liyuan Ge, Cheng Liu, Xiaojun Tian and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Zhigang Chen *Department of Urology, Beijing Haidian Hospital (Haidian Section of Peking University Third Hospital), Beijing, 100080, China.
Junbo Yang *Synthetic and Functional Biomolecules Center, Beijing National Laboratory for Molecular Sciences, Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education, College of Chemistry and Molecular Engineering, Peking University, Beijing, 100871, China.
Wei Zhang *Synthetic and Functional Biomolecules Center, Beijing National Laboratory for Molecular Sciences, Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education, College of Chemistry and Molecular Engineering, Peking University, Beijing, 100871, China.
Yang QianSynthetic and Functional Biomolecules Center, Beijing National Laboratory for Molecular Sciences, Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education, College of Chemistry and Molecular Engineering, Peking University, Beijing, 100871, China.
Nan ZhangSynthetic and Functional Biomolecules Center, Beijing National Laboratory for Molecular Sciences, Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education, College of Chemistry and Molecular Engineering, Peking University, Beijing, 100871, China.
Zixin ChenSynthetic and Functional Biomolecules Center, Beijing National Laboratory for Molecular Sciences, Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education, College of Chemistry and Molecular Engineering, Peking University, Beijing, 100871, China.
Min LuDepartment of Urology, Peking University Third Hospital, Beijing, 100191, China.
Liyuan GeDepartment of Urology, Peking University Third Hospital, Beijing, 100191, China.
Cheng LiuDepartment of Urology, Peking University Third Hospital, Beijing, 100191, China.
Xiaojun TianDepartment of Urology, Peking University Third Hospital, Beijing, 100191, China.
Guifang JiaSynthetic and Functional Biomolecules Center, Beijing National Laboratory for Molecular Sciences, Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education, College of Chemistry and Molecular Engineering, Peking University, Beijing, 100871, China. guifangjia@pku.edu.cn.
Lulin MaDepartment of Urology, Peking University Third Hospital, Beijing, 100191, China. puth_malulin@163.com.
Baoguo LiDepartment of Urology, Beijing Haidian Hospital (Haidian Section of Peking University Third Hospital), Beijing, 100080, China. libaoguo_hdyy@163.com.

Funding

Beijing Haidian Hospital research fund KYQ 2022018Beijing Natural Science Foundation. Z200010the National Basic Research Program of China 2019YFA0802201
6 · The paper itself

Abstract

N6-methyladenosine (m

Indexed as

AdenosineCarcinoma, Renal CellKidney NeoplasmsBiomarkers, TumorFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticHumansMalePrognosisRNA, MessengerAdenosineBiomarkers, TumorN-methyladenosineRNA, MessengerChromophobe renal cell carcinomaN 6-methyladenosinePrognostic indicatorTranscriptome

Identifiers

PMID39334021
PMCPMC11438101

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.